CEHON

Salvador 45995-000

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma — Completed
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early